RecruitingNCT06657846
HRQoL and Financial Toxicity in Patients With VEXAS Syndrome
Studying VEXAS syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Enrollment
- 100 target
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2024 – 2025
Study locations (17)
- Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
- Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia, Bergamo, Italy
- Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
- Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy
- Istituto Di Candiolo - Fondazione Del Piemonte Per L'Oncologia - Irccs - Centro Trapianti, Candiolo, Italy
- Aou Careggi - Firenze - Sod Ematologia, Florence, Italy
- Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora, Milan, Italy
- Irccs Ospedale S. Raffaele - Milano - Uo Oncoematologia, Milan, Italy
- Aou Federico Ii - Napoli - Uoc Ematologia, Naples, Italy
- Aou Di Padova - Uo Ematologia, Padua, Italy
- Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia, Pavia, Italy
- Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia, Reggio Emilia, Italy
- Aou Policlinico Tor Vergata - Roma - Uoc Trapianto Cellule Staminali, Roma, Italy
- Ististuto Clinico Humanitas - Rozzano - Uo Oncologia Medica Ed Ematologia, Rozzano, Italy
- Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06657846 on ClinicalTrials.govOther trials for VEXAS syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07102849Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research StudyNational Heart, Lung, and Blood Institute (NHLBI)
- RECRUITINGPHASE2NCT06782373A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Swedish Orphan Biovitrum
- RECRUITINGPHASE1NCT06538181Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeWashington University School of Medicine
- RECRUITINGNCT06377462Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial CollectionTechnische Universität Dresden